{
    "2020-09-03": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Medicare Coverage for Libre 2 Boosts Abbott's CGM Prospects",
                "features": {
                    "keywords": [
                        "Medicare",
                        "Coverage",
                        "Libre 2",
                        "Abbott",
                        "CGM"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Trial",
                        "Esprit™",
                        "BTK",
                        "Drug-Eluting",
                        "Resorbable",
                        "Scaffold"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Fulgent Shares Up 10% On COVID-19 Testing Deal For New York Schools",
                "features": {
                    "keywords": [
                        "Fulgent",
                        "Shares",
                        "Up",
                        "COVID-19",
                        "Testing",
                        "Deal",
                        "New York",
                        "Schools"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "education"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}